More health lost than gained from NHS spending on new medicines
News | Posted on Tuesday 17 December 2024
New medicines approved by the NHS spending watchdog NICE may have helped some patients, but their rollout has come at a heavy cost to the health of many others due to loss of funding in other areas of care, a new study reveals.
Beth Woods, Senior Research Fellow at Centre for Health Economics at University of York, and one of the authors of the study, said: "This work shows that there is a need to reform pharmaceutical pricing policy in England to better serve the health needs of all patients served by the NHS.”